Drugs in the Pipeline: ALKS–5461

Since our feature article on “New Antidepressants” in the May 2012 TCPR, you may have heard some buzz about yet another new antidepressant undergoing clinical trials, this one with the less-than-sexy name ALKS-5461. Some news outlets have promoted it as “revolutionary.” What exactly is it?

Current Subscribers

Purchase a subscription

To view the full content, you need to purchase a subscription.